Fate Therapeutics Receives $8,000,000 New Financing Round

  • Feed Type
  • Date
    5/18/2015
  • Company Name
    Fate Therapeutics
  • Mailing Address
    3535 General Atomics Court San Diego, CA 92121 USA
  • Company Description
    The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues.
  • Website
    http://www.fatetherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy